On August 10, 2022 Emergent BioSolutions Inc. (NYSE: EBS) reported that members of the company’s executive management team will participate in the following investor conferences (Press release, Emergent BioSolutions, AUG 10, 2022, View Source [SID1234618054]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

12th Annual Midwest IDEAS Investor Conference
Chicago, IL
August 24, 2022 – presentation scheduled at 5:15 PM central time
View Source
Wells Fargo 2022 Healthcare Conference
Boston, MA
September 8, 2022 – fireside chat scheduled at 9:10 AM eastern time
Wells Fargo 2022 Leveraged Finance Conference
Nashville, TN
September 8, 2022 – fireside chat scheduled at 2:30 PM central time
Morgan Stanley 20th Annual Global Healthcare Conference
New York, NY
September 12-14, 2022 – presentation date and time will be updated on the Emergent website as the information becomes available
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.